Johnson & Johnson (JNJ)

137.73
0.95 0.69
NYSE : Health Technology
Prev Close 138.68
Open 137.79
Day Low/High 137.45 / 138.97
52 Wk Low/High 118.62 / 148.32
Volume 3.79M
Avg Volume 6.10M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 373.04B
EPS 0.50
P/E Ratio 123.05
Div & Yield 3.60 (2.49%)
J&J Makes Offer to Buy Japanese Cosmetics Firm Ci:z

J&J Makes Offer to Buy Japanese Cosmetics Firm Ci:z

The U.S. healthcare company has owned 19.9% of Ci:z since July 2016.

Johnson & Johnson Announces Offer To Acquire Ci:z Holdings Co., Ltd.

Johnson & Johnson Announces Offer To Acquire Ci:z Holdings Co., Ltd.

Acquisition is Expected to Expand J&J's Consumer Portfolio of Science-based Dermocosmetic Beauty Products

Weekly Roundup

The markets endured another round of volatility this week.

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.

Dow Surges More Than 540 Points on Strong Bank Earnings; Nasdaq Gains 2.9%

Dow Surges More Than 540 Points on Strong Bank Earnings; Nasdaq Gains 2.9%

Stocks post sharp gains on Tuesday, getting a boost from better-than-expected earnings from investment banks Morgan Stanley and Goldman Sachs.

Trimming Emerson Electric

We are using the broader market's strength to cut our position in EMR and increase our optionality.

We're Encouraged by Johnson & Johnson's Top and Bottom Line Beat

Pharmaceutical showed it can deliver on its above-market growth expectations, and the consumer side came in ahead of consensus.

Jim Cramer: An Absence of Negatives Is a Real Positive

Jim Cramer: An Absence of Negatives Is a Real Positive

This is what the market looks like when the Fed says nothing and the president isn't ranting about something.

Jim's Daily Rundown

Jim discusses today's market, how to treat an oversold rally, his conference last Saturday, and many stocks.

Netflix Is Tonight's Big Report: Here's How I Would Play It

Netflix Is Tonight's Big Report: Here's How I Would Play It

This is a battleground stock that has made big moves in both directions on earnings in the past.

Johnson & Johnson Bumps Full-Year Earnings Guidance Higher After Solid Q3

Johnson & Johnson Bumps Full-Year Earnings Guidance Higher After Solid Q3

Johnson & Johnson posts solid third-quarter earnings Tuesday, and boosts its full-year profit guidance.

U.S. Stocks Set For Solid Open as Q3 Earnings Impress; Goldman Boosts Dow

U.S. Stocks Set For Solid Open as Q3 Earnings Impress; Goldman Boosts Dow

Global stocks edged cautiously higher Tuesday, while U.S. earnings helped equity futures rise firmly into positive territory, even as investors continue to eye developments in Saudi Arabia linked to the disappearance of prominent journalist Jamal Khashoggi and fret over further signals of a trade war-related slowdown in China.

Here's How to Play Adobe on Killer Growth Forecast: Market Recon

Here's How to Play Adobe on Killer Growth Forecast: Market Recon

Adobe released new guidance for the rest of this year and 2019. With 20% growth in the cards, this name is a buy.

Netflix, Goldman Sachs, Paul Allen, Google and Ford - 5 Things You Must Know

Netflix, Goldman Sachs, Paul Allen, Google and Ford - 5 Things You Must Know

U.S. stock futures rise on Tuesday and global stocks edge mostly higher even as investors continue to eye developments in Saudi Arabia linked to the disappearance of journalist Jamal Khashoggi; Netflix, Goldman Sachs and IBM report earnings on Tuesday; Microsoft co-founder Paul Allen dies; Google's CEO defends plans for a censored search engine in China.

Johnson & Johnson Reports 2018 Third-Quarter Results:

Johnson & Johnson Reports 2018 Third-Quarter Results:

2018 Third-Quarter Sales of $20.3 Billion Increased 3.6% versus 2017

Earnings Primer for the Week

UnitedHealth Group, Johnson and Johnson, Goldman Sachs, Abbott Laboratories, Danaher and Textron are just some of the companies reporting earnings this week.

Bye, Bye, Bye Sears: The Week Ahead

Bye, Bye, Bye Sears: The Week Ahead

Earnings season is upon us.

Jim's Daily Rundown

Jim provides his market outlook, shares his view on the financials and the aerospace/defense industry and explains some of our selling disciplines.

Netflix, IBM and UnitedHealth Group Among Companies Reporting Monday, Tuesday

Netflix, IBM and UnitedHealth Group Among Companies Reporting Monday, Tuesday

A look at some of the major companies in the S&P 500 slated to report financial results in the early part of next week.

Brace for Impact: Cramer's 'Mad Money' Recap (Friday 10/12/18)

Brace for Impact: Cramer's 'Mad Money' Recap (Friday 10/12/18)

This earnings season could be full of surprises. Jim Cramer has your game plan for next week.

Weekly Roundup

Markets had one of the most volatile weeks in recent memory.

Market Futures Point to a Strong Open Friday

Selling pressure appears to have abated for now as we have reached earnings season.

Adding to Johnson & Johnson

We are putting a small amount of capital to work by scooping up more shares of JNJ.

Markets Yo-Yo to Start Thursday

Be patient and let the market come in a little bit if you haven't bought yet.

Adding to Johnson & Johnson

Now that JNJ has fallen firmly below our basis, we are pouncing on this opportunity to scale deeper into this position.

Reflections on Wednesday's Selloff

The volatility may continue, but we'll be back Thursday putting our cash to work.

Our Game Plan for This Tumultuous Market

Let's review the portfolio and where we see opportunities in the market.

Adding to Palo Alto Networks

We are picking at a small amount of PANW as we look to reallocate the cash we raised through our exit of NUE.

The New #16 Most Shorted Dow Component: Johnson & Johnson

The New #16 Most Shorted Dow Component: Johnson & Johnson

The most recent short interest data has been released for the 09/28/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B (Buy)